Adverum Biotechnologies, Inc. (LON: 0HA3)
London
· Delayed Price · Currency is GBP · Price in USD
4.492
+0.072 (1.62%)
At close: Jan 22, 2025
Adverum Biotechnologies Employees
Adverum Biotechnologies had 121 employees as of December 30, 2023. The number of employees decreased by 2 or -1.63% compared to the previous year.
Employees
121
Change (1Y)
-2
Growth (1Y)
-1.63%
Revenue / Employee
6.17K GBP
Profits / Employee
-580.30K GBP
Market Cap
75.50M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
Shell | 103,000 |
HSBC Holdings | 220,861 |
Unilever | 128,377 |
Rio Tinto Group | 57,000 |
RELX PLC | 36,500 |
BP p.l.c. | 87,800 |
British American Tobacco p.l.c. | 46,725 |
Adverum Biotechnologies News
- 6 weeks ago - Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Adverum: Ixo-Vec Could Reduce Treatment Burden For Wet-AMD Patients - Seeking Alpha
- 2 months ago - Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements - GlobeNewsWire
- 2 months ago - Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones - GlobeNewsWire
- 3 months ago - Adverum Biotechnologies Appoints Jason L. Mitchell as Chief Commercial Officer as it Prepares to Initiate Pivotal Program - GlobeNewsWire
- 5 months ago - Adverum Biotechnologies to Participate in Upcoming Fall Investor Conferences - GlobeNewsWire
- 6 months ago - Adverum Biotechnologies to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - GlobeNewsWire